AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy

Clinical trial NCT00102323 · COMPLETED

Trial details

NCT number: NCT00102323
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Thrombocytopenia Idiopathic Thrombocytopenic Purpura

Start date: 2005-03-29
Primary completion: 2006-09-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.